[1] |
YANG Qifen, ZHAO Huiliang, GUO Yongsheng, QU Jinglian.
The Impact of the Jagged1/Notch1 Signalling Pathway on Endothelial-mesenchymal Transition in Idiopathic Pulmonary Fibrosis
[J]. Chinese General Practice, 2025, 28(25): 3151-3160.
|
[2] |
HAN Bing, DU Shuzhen, MENG Xiaoxue, ZHANG Lu, CHEN Zixian, TENG Fengling.
Plasma Periostin Levels Correlated with Myocardial Fibrosis in Patients with Heart Failure with Different Ejection Fraction
[J]. Chinese General Practice, 2025, 28(24): 2979-2984.
|
[3] |
WU Sha, ZHANG Daiyi, LI Jin, XUAN Qinkao, QIAN Xiaodong, ZHU Chuanwu, PU Jianhong, ZHU Li.
Correlation Analysis and Model Construction of Metabolic Associated Fatty Liver Disease and Hyperglycemia Based on a Health Examination Cohort
[J]. Chinese General Practice, 2025, 28(23): 2861-2869.
|
[4] |
SHEN Mingmei, LYU Yujiao, ZHANG Shangbo, ZHOU Xinchen, DONG Shuhan, ZHANG Zhuo, LIU Yongchao.
Calcium Sensitive Receptors Mediate Signaling Pathways in Myocardial Injury
[J]. Chinese General Practice, 2025, 28(18): 2301-2306.
|
[5] |
ZHU Ziyi, HE Guixin, QIN Weibin, SONG Hui, ZHANG Liwen, TANG Weizhi, YANG Feifei, LIU Lingyun, OUYANG Bin.
Research Progress of Mitochondrial Autophagy in Improving Myocardial Fibrosis after Myocardial Infarction and Intervention of Traditional Chinese Medicine
[J]. Chinese General Practice, 2025, 28(18): 2294-2300.
|
[6] |
NIE Yuanyuan, FANG Da, XU Hao, YANG Donghui, BI Yan, GU Tianwei.
Clinical Characteristics and Cardiovascular Disease Risk of Type 2 Diabetes Populations with Different Liver Fibrosis Risks
[J]. Chinese General Practice, 2025, 28(15): 1847-1854.
|
[7] |
TAN Huihui, MAO Wei, YANG Zihan.
Research Progress of Annexin A1 in Respiratory Diseases
[J]. Chinese General Practice, 2025, 28(13): 1668-1673.
|
[8] |
ZHUO Lili, QU Huanjia, ZHANG Qiuling.
The Effect of Type 2 Diabetes Mellitus and Obesity on FIB-4 Index Screening for Early Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(11): 1354-1360.
|
[9] |
HUANG Lihui, SHU Juan, TAO Huihui, BAO Hairong.
Progress in Treatment of Post Inflammatory Pulmonary Fibrosis Induced by SARS-CoV-2 Infection
[J]. Chinese General Practice, 2024, 27(32): 4085-4092.
|
[10] |
REN Lingxuan, LU Ziqi, QI Wei, FENG Zhijie.
Functional Analysis of Macrophages in the Progression of Liver Cirrhosis and Liver Cancer
[J]. Chinese General Practice, 2024, 27(29): 3654-3663.
|
[11] |
LI Yong, LI Zhanhu, JIN Bowei, LI Yuan, ZHANG Hongbo, SU Yakun, YAN Xiaoju.
Correlation between Serum Complement C1q/Tumor Necrosis Factor-related Protein 5 Levels and the Severity of Coronary Artery Lesions and Myocardial Fibrosis Markers in Patients with Acute Coronary Syndrome
[J]. Chinese General Practice, 2024, 27(27): 3365-3371.
|
[12] |
QIN Fang, MA Tiantian, YU Zifu, LIU Xihua.
Study on Mechanism of Myocardial Fibrosis in ApoE-/- Atherosclerotic Mice Inhibited by Aerobic Exercise
[J]. Chinese General Practice, 2024, 27(05): 557-562.
|
[13] |
HE Jia, LI Yongping, WEI Feng, LIU Meilan, WU Yaling, SHAO Longge.
Correlation of lncRNA NEAT1 and miRNA-182-5p with the Risk of Liver Fibrosis in Type 2 Diabetes Mellitus Patients with MAFLD
[J]. Chinese General Practice, 2024, 27(03): 300-307.
|
[14] |
XU Lili, HONG Yunzhe, LI Zhihui, YU Ningxia, DI Jiaqi, YANG Shuguang, LIN Qingqing, YU Xueqing.
Prognostic Biomarkers in Idiopathic Pulmonary Fibrosis: a Recent Review
[J]. Chinese General Practice, 2023, 26(03): 372-379.
|
[15] |
Fangyuan CONG, Qian XUE, Lihua DENG, Luying ZHU, Jingtong WANG.
Correlation between Nonalcoholic Fatty Liver Disease and Early Left Ventricular Diastolic Dysfunction
[J]. Chinese General Practice, 2022, 25(26): 3290-3297.
|